Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 18, 2026

Single Port Donor Nephrectomy
07:17

Single Port Donor Nephrectomy

Published on: March 12, 2011

[Laparoendoscopic single-site surgery in urology using reusable systems].

C Schwentner1, T Todenhöfer, J Seibold

  • 1Klinik für Urologie, Eberhard-Karls-Universität, Tübingen. christian.schwentner@med.uni-tuebingen.de

Der Urologe. Ausg. A
|September 22, 2012
PubMed
Summary

A reusable platform for laparoendoscopic single-site surgery (LESS) is effective across multiple urological procedures. This approach offers favorable outcomes and may reduce costs, increasing LESS adoption.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Larcher et al. The OpeRa trial: the active role of the patient in the clinical decision-making process and surgical planning.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Impact of sociodemographic and socioeconomic factors on functional and health-related quality of life outcomes 24 months after radical prostatectomy.

Journal of cancer research and clinical oncology·2025
Same author

Parkinson's paradox: alpha-synuclein's selective strike on SNc dopamine neurons over VTA.

NPJ Parkinson's disease·2025
Same author

Avelumab plus sacituzumab govitecan versus avelumab monotherapy as first-line maintenance treatment in patients with advanced urothelial carcinoma: JAVELIN Bladder Medley interim analysis.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Retrospective analysis of different application methods in intratympanic glucocorticoid therapy for treatment of idiopathic SSNHL: A comparative outcome study.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·2025
Same author

Pembrolizumab plus enzalutamide versus placebo plus enzalutamide for chemotherapy-naive metastatic castration-resistant prostate cancer: the randomized, double-blind, phase III KEYNOTE-641 study.

Annals of oncology : official journal of the European Society for Medical Oncology·2025

Area of Science:

  • Urology
  • Minimally Invasive Surgery
  • Surgical Technology

Background:

  • Disposable platforms for laparoendoscopic single-site surgery (LESS) are common but costly.
  • Cost remains a significant barrier to the widespread adoption of LESS procedures.
  • There is a need for cost-effective LESS solutions.

Purpose of the Study:

  • To evaluate the feasibility and outcomes of the first completely reusable LESS platform.
  • To assess the applicability of reusable LESS in various urological surgeries.
  • To determine if a reusable platform can overcome cost limitations of LESS.

Main Methods:

  • LESS procedures were performed in 52 patients using a novel reusable single-port device (X-ConeR).
  • Procedures included nephrectomy, adrenalectomy, partial nephrectomy, pyeloplasty, renal cyst ablation, pelvic lymphadenectomy, and lymphocele ablation.

Related Experiment Videos

Last Updated: May 18, 2026

Single Port Donor Nephrectomy
07:17

Single Port Donor Nephrectomy

Published on: March 12, 2011

  • Perioperative data, pain scores (VAS), and complications (Clavien classification) were collected.

    • Main Results:

    • The reusable LESS platform was successfully applied to diverse urological indications.
    • No open conversions were required; 3 cases needed conversion to standard laparoscopy.
    • Low complication rates (Clavien II/III in 3 patients) and favorable outcomes (e.g., low VAS, minimal blood loss) were observed.

    Conclusions:

    • The reusable LESS platform is versatile and effective for various urological procedures.
    • This approach yields good functional and cosmetic results.
    • Reusable LESS platforms can potentially lower costs and improve accessibility.